These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 22966891

  • 21. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F, Koehm M, Burkhardt H.
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [Abstract] [Full Text] [Related]

  • 22. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
    Rajakulendran S, Gadsby K, Deighton C.
    Musculoskeletal Care; 2008 Dec; 6(4):233-45. PubMed ID: 18702106
    [Abstract] [Full Text] [Related]

  • 23. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.
    Kalden JR, Schattenkirchner M, Sörensen H, Emery P, Deighton C, Rozman B, Breedveld F.
    Arthritis Rheum; 2003 Jun; 48(6):1513-20. PubMed ID: 12794818
    [Abstract] [Full Text] [Related]

  • 24. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [Abstract] [Full Text] [Related]

  • 25. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.
    Wiacek R, Kolossa K, Jankowski T, Jeka S, Karmowski A, Karmowski M, Gworys B.
    Adv Clin Exp Med; 2012 Jul; 21(3):337-42. PubMed ID: 23214197
    [Abstract] [Full Text] [Related]

  • 26. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A.
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [Abstract] [Full Text] [Related]

  • 27. Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients.
    Tchetverikov I, Kraan MC, van El B, Hanemaaijer R, DeGroot J, Huizinga TW.
    Ann Rheum Dis; 2008 Jan; 67(1):128-30. PubMed ID: 17875551
    [Abstract] [Full Text] [Related]

  • 28. Leflunomide in Pakistani patients with rheumatoid arthritis: prospective study in daily rheumatology practice.
    Ahmad NM, Farman S, Saeed MA, Hameed R, Umair M, Ghafoor E.
    Int J Rheum Dis; 2011 Feb; 14(1):48-54. PubMed ID: 21303481
    [Abstract] [Full Text] [Related]

  • 29. Leflunomide: a new DMARD for rheumatoid arthritis.
    Emery P.
    Hosp Med; 2000 May; 61(5):344-7. PubMed ID: 10953742
    [Abstract] [Full Text] [Related]

  • 30. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
    Herrmann ML, Schleyerbach R, Kirschbaum BJ.
    Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294
    [Abstract] [Full Text] [Related]

  • 31. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN, Jansen TL, Mourad L, Houtman PM, Bruyn GA, Griep EN, Wilffert B, Tobi H, Brouwers JR.
    Br J Clin Pharmacol; 2004 Aug; 58(2):201-8. PubMed ID: 15255803
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Human dihydroorotate dehydrogenase inhibitors, a novel approach for the treatment of autoimmune and inflammatory diseases.
    Leban J, Vitt D.
    Arzneimittelforschung; 2011 Aug; 61(1):66-72. PubMed ID: 21355448
    [Abstract] [Full Text] [Related]

  • 35. Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis.
    Pereira ICP, Sousa NCF, Pereira DMS, Mendes SJF, Muniz TF, Colares VLP, Silva BLR, Monteiro CRAV, Martins MMRS, Fernandes AMR, Fernandes ES.
    An Acad Bras Cienc; 2018 Aug; 90(2 suppl 1):2161-2166. PubMed ID: 29947664
    [Abstract] [Full Text] [Related]

  • 36. The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
    Smolen JS, Emery P, Kalden JR, Van Riel PL, Dougados M, Strand CV, Breedveld FC.
    J Rheumatol Suppl; 2004 Jun; 71():13-20. PubMed ID: 15170903
    [Abstract] [Full Text] [Related]

  • 37. Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide.
    Dziedziejko V, Kurzawski M, Safranow K, Ossowski A, Piatek J, Parafiniuk M, Chlubek D, Pawlik A.
    Eur J Clin Pharmacol; 2012 Apr; 68(4):371-7. PubMed ID: 21997404
    [Abstract] [Full Text] [Related]

  • 38. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS, Park YW, Park JJ, Kang YM, Nam EJ, Kim SI, Lee JH, Yoo WH, Lee SI.
    Scand J Rheumatol; 2009 Apr; 38(1):11-4. PubMed ID: 19191187
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.
    Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, van Riel PL, Nordström DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF, Gabay C.
    Ann Rheum Dis; 2012 Mar; 71(3):374-7. PubMed ID: 21972242
    [Abstract] [Full Text] [Related]

  • 40. [Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis].
    Jakob A, Porstmann R, Rompel R.
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):324-7. PubMed ID: 16638062
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.